Skip to main
STE

STERIS (STE) Stock Forecast & Price Target

STERIS (STE) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Steris is poised for continued growth with its strong market position as the global leader in contract sterilization services, solid revenue growth in key segments, and recent acquisitions. The company also plans to invest in a new facility to support future growth and has a balanced approach to capital allocation. There are potential risks, such as decreases in healthcare spending and changes in tariff policies, but overall the company's positive outlook is supported by its strong fundamentals and strategic investments.

Bears say

Steris is facing numerous risks, as it is sensitive to procedure volumes, supply chain disruptions, and inflationary pressures, which could impact its financial performance. Additionally, its growth in the Applied Sterilization Technologies segment is expected to be lumpy due to light volumes and customers destocking inventory. The company's management has reaffirmed its full-year growth outlook, but ongoing challenges in the market may hinder its progress.

STERIS (STE) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STERIS and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STERIS (STE) Forecast

Analysts have given STERIS (STE) a Buy based on their latest research and market trends.

According to 3 analysts, STERIS (STE) has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $271.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $271.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STERIS (STE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.